UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): August 27, 2007
AMAG PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
0-14732 | | 04-2742593 |
(Commission File Number) | | (IRS Employer Identification No.) |
| | |
125 CambridgePark Drive | | |
Cambridge, Massachusetts | | 02140 |
(Address of principal executive offices) | | (Zip Code) |
(617) 498-3300
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01. Entry into a Material Definitive Agreement.
On August 27, 2007, AMAG Pharmaceuticals, Inc., or the Company, amended its existing lease for its principal executive offices located at 125 CambridgePark Drive, Cambridge, Massachusetts 02140. Pursuant to the amended lease, the Company leased an additional 8,227 square feet of office space and correspondingly increased the annual base rent payable to the landlord under such lease by $320,853. The Company will also pay as additional rent an amount equal to 3.15% of “annual operating costs” (as defined in the amended lease) attributable to a portion of the new office space and 1.32% of “annual operating costs” attributable to the remaining portion of the new office space. The term of the lease was not affected by the amendment.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
The Company hereby files the following exhibit:
10.1 | | Second Amendment to Lease, dated as of August 27, 2007, by and between AMAG Pharmaceuticals, Inc. and W2007 CPD Realty, L.L.C. |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| AMAG PHARMACEUTICALS, INC. |
| | |
| By: | /s/ Joseph L. Farmer |
| | Joseph L. Farmer |
| | General Counsel and Vice |
| | President of Legal Affairs |
| | |
| Date: August 27, 2007 |
3
EXHIBIT INDEX
Exhibit Number | | Description |
10.1 | | Second Amendment to Lease, dated as of August 27, 2007, by and between AMAG Pharmaceuticals, Inc. and W2007 CPD Realty, L.L.C. |
4
